Fund Holdings — SILVERARC CAPITAL MANAGEMENT, LLC

Total Portfolio Value:
$324.24M
Total Bought:
$157.82M
Total Sold:
$120.22M
Net Transaction:
+$37.60M
Securities
▲▼
SharesValue
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
Merus NVEQUITIES500,000645,581+145,581$11.79M$17.75M5.48%+$5.96M
Mersana Therapeutics IncEQUITIES5,000,0006,420,136+1,420,136$6.35M$14.89M4.59%+$8.54M
Morphic Holding IncEQUITIES590,829500,042-90,787$13.54M$14.44M4.45%+$905.3K
Nuvalent IncEQUITIES0193,000+193,000$0$14.20M4.38%+$14.20M
Poseida Therapeutics IncEQUITIES3,567,9853,705,779+137,794$8.49M$12.45M3.84%+$3.96M
MacroGenics, Inc.EQUITIES(MGNX)1,264,1581,258,641-5,517$5.89M$12.11M3.73%+$6.22M
Rocket Pharmaceuticals, Inc.EQUITIES(RCKT)0382,672+382,672$0$11.47M3.54%+$11.47M
Medtronic plcEQUITIES(MDT)0135,000+135,000$0$11.12M3.43%+$11.12M
SanofiEQUITIES(SNY)0220,000+220,000$0$10.94M3.37%+$10.94M
ORIC Pharmaceuticals, Inc.EQUITIES(ORIC)1,123,3451,170,000+46,655$6.80M$10.76M3.32%+$3.97M
Celldex Therapeutics, Inc.EQUITIES(CLDX)0247,215+247,215$0$9.80M3.02%+$9.80M
Olema Pharmaceuticals, Inc.EQUITIES(OLMA)407,801573,830+166,029$5.04M$8.05M2.48%+$3.01M
Rhythm Pharmaceuticals, Inc.EQUITIES(RYTM)260,537174,248-86,289$5.97M$8.01M2.47%+$2.04M
UroGen Pharma Ltd.EQUITIES(URGN)508,883525,404+16,521$7.13M$7.88M2.43%+$751.6K
Xenon Pharmaceuticals Inc.EQUITIES(XENE)53,996163,168+109,172$1.84M$7.52M2.32%+$5.67M
Veracyte, Inc.EQUITIES(VCYT)239,571247,723+8,152$5.35M$6.81M2.10%+$1.47M
Praxis Precision Medicines, Inc.EQUITIES(PRAX)0283,841+283,841$0$6.32M1.95%+$6.32M
Akero Therapeutics IncEQUITIES31,336249,254+217,918$1.58M$5.82M1.79%+$4.24M
Pliant Therapeutics, Inc.EQUITIES(PLRX)250,409318,524+68,115$4.34M$5.77M1.78%+$1.43M
Intra-Cellular Therapies IncEQUITIES208,73080,000-128,730$10.87M$5.73M1.77%-$5.14M
Cogent Biosciences, Inc.EQUITIES(COGT)651,372966,748+315,376$6.35M$5.68M1.75%-$666.4K
Alpine Immune Sciences IncEQUITIES0297,789+297,789$0$5.68M1.75%+$5.68M
Gossamer Bio, Inc.EQUITIES(GOSS)6,130,2686,130,2680$5.11M$5.59M1.73%+$488.6K
Intuitive Surgical, Inc.EQUITIES(ISRG)015,808+15,808$0$5.33M1.64%+$5.33M
TELA Bio, Inc.EQUITIES(TELA)490,471795,080+304,609$3.92M$5.26M1.62%+$1.34M
Biogen Inc.EQUITIES(BIIB)28,06920,000-8,069$7.21M$5.18M1.60%-$2.04M
CymaBay Therapeutics IncEQUITIES590,000218,975-371,025$8.80M$5.17M1.60%-$3.62M
Caribou Biosciences, Inc.EQUITIES(CRBU)892,786900,818+8,032$4.27M$5.16M1.59%+$894.2K
Scholar Rock Holding CorporationEQUITIES(SRRK)9,711270,000+260,289$68.9K$5.08M1.57%+$5.01M
Penumbra, Inc.EQUITIES(PEN)020,000+20,000$0$5.03M1.55%+$5.03M
Insmed IncorporatedEQUITIES(INSM)150,387155,504+5,117$3.80M$4.82M1.49%+$1.02M
Sarepta Therapeutics, Inc.EQUITIES(SRPT)9,19746,884+37,687$1.11M$4.52M1.39%+$3.41M
DexCom, Inc.EQUITIES(DXCM)031,000+31,000$0$3.85M1.19%+$3.85M
Solid Biosciences IncEQUITIES0594,855+594,855$0$3.65M1.13%+$3.65M
United Therapeutics CorporationEQUITIES(UTHR)31,42416,360-15,064$7.10M$3.60M1.11%-$3.50M
Terns Pharmaceuticals IncEQUITIES500,000516,999+16,999$2.52M$3.36M1.03%+$840.3K
Cerus CorporationEQUITIES(CERS)1,203,8901,499,851+295,961$1.95M$3.24M1.00%+$1.29M
Kodiak Sciences Inc.EQUITIES(KOD)1,114,4611,000,000-114,461$2.01M$3.04M0.94%+$1.03M
Biohaven Ltd.EQUITIES(BHVN)10,00070,695+60,695$260.1K$3.03M0.93%+$2.77M
MoonLake ImmunotherapeuticsEQUITIES(MLTX)050,000+50,000$0$3.02M0.93%+$3.02M
Soleno Therapeutics IncEQUITIES370,00073,665-296,335$10.92M$2.97M0.91%-$7.95M
Evogene LtdEQUITIES3,100,0003,100,0000$1.82M$2.60M0.80%+$785.9K
Mirum Pharmaceuticals, Inc.EQUITIES(MIRM)110,11480,811-29,303$3.48M$2.39M0.74%-$1.09M
Zura Bio LimitedEQUITIES(ZURA)404,040462,997+58,957$2.67M$2.16M0.67%-$504.5K
Annexon, Inc.EQUITIES(ANNX)399,716417,429+17,713$943.3K$1.90M0.58%+$951.8K
Compugen Ltd.EQUITIES(CGEN)350,188940,000+589,812$325.7K$1.86M0.57%+$1.54M
argenx SEEQUITIES(ARGX)04,826+4,826$0$1.84M0.57%+$1.84M
89bio IncEQUITIES60,247158,719+98,472$930.2K$1.77M0.55%+$842.7K
PMV Pharmaceuticals, Inc.EQUITIES(PMVP)0550,000+550,000$0$1.71M0.53%+$1.71M
Altimmune, Inc.EQUITIES(ALT)0150,000+150,000$0$1.69M0.52%+$1.69M
Intellia Therapeutics, Inc.EQUITIES(NTLA)53,01854,822+1,804$1.68M$1.67M0.52%-$4.9K
BioCryst Pharmaceuticals, Inc.EQUITIES(BCRX)791,671248,728-542,943$5.61M$1.49M0.46%-$4.12M
KalVista Pharmaceuticals IncEQUITIES228,934111,734-117,200$2.20M$1.37M0.42%-$835.9K
Molecular Templates IncEQUITIES354,608354,6080$2.24M$1.32M0.41%-$918.4K
Trevi Therapeutics, Inc.EQUITIES(TRVI)927,415863,883-63,532$2.02M$1.16M0.36%-$864.2K
Schrödinger, Inc.EQUITIES(SDGR)30,31131,117+806$856.9K$1.11M0.34%+$257.1K
Viridian Therapeutics, Inc.EQUITIES(VRDN)47,43850,438+3,000$727.7K$1.10M0.34%+$370.8K
Immunovant, Inc.EQUITIES(IMVT)020,000+20,000$0$842.6K0.26%+$842.6K
Apellis Pharmaceuticals IncEQUITIES
COM
010,000+10,000$0$598.6K0.18%+$598.6K
Karyopharm Therapeutics Inc.EQUITIES(KPTI)561,955561,9550$753.0K$486.1K0.15%-$266.9K
Aligos Therapeutics IncEQUITIES631,887668,512+36,625$472.0K$443.9K0.14%-$28.1K
Relmada Therapeutics, Inc.EQUITIES(RLMD)100,000100,0000$300.0K$414.0K0.13%+$114.0K
Rezolute, Inc.EQUITIES(RZLT)433,240157,085-276,155$571.9K$155.9K0.05%-$416.0K
Rocket Pharmaceuticals, Inc.WARRANTS(RCKT)104,828104,8280$17.8K$51.4K0.02%+$33.5K
Aerovate Therapeutics IncEQUITIES100,0000-100,000$1.36M$0—-$1.36M
Alkermes PlcEQUITIES(ALKS)41,4550-41,455$1.16M$0—-$1.16M
BioMarin Pharmaceutical IncEQUITIES(BMRN)10,0000-10,000$884.8K$0—-$884.8K
Clene IncEQUITIES(CLNN)500,0000-500,000$247.9K$0—-$247.9K
Crinetics Pharmaceuticals IncEQUITIES(CRNX)220,0000-220,000$6.54M$0—-$6.54M
Eliem Therapeutics IncEQUITIES(CLYM)121,1100-121,110$318.5K$0—-$318.5K
Eloxx Pharmaceuticals IncEQUITIES54,0750-54,075$260.1K$0—-$260.1K
Gilead Sciences IncEQUITIES(GILD)62,7890-62,789$4.71M$0—-$4.71M
Humana IncEQUITIES(HUM)10,0000-10,000$4.87M$0—-$4.87M
ImmunoGen IncEQUITIES1,307,4350-1,307,435$20.75M$0—-$20.75M
Krystal Biotech IncEQUITIES(KRYS)71,5310-71,531$8.30M$0—-$8.30M
Mirati Therapeutics IncEQUITIES200,0000-200,000$8.71M$0—-$8.71M
Novo Nordisk A/SEQUITIES(NVO)60,0000-60,000$5.46M$0—-$5.46M
Point Biopharma Global IncEQUITIES93,7000-93,700$625.0K$0—-$625.0K
Praxis Precision Medicines IncEQUITIES4,117,9200-4,117,920$7.04M$0—-$7.04M
Prothena Corporation PLCEQUITIES
SHS
26,6290-26,629$1.28M$0—-$1.28M
Roivant Sciences LtdEQUITIES(ROIV)100,0000-100,000$1.17M$0—-$1.17M
Sagimet Biosciences IncEQUITIES(SGMT)100,0000-100,000$880.0K$0—-$880.0K
Syndax Pharmaceuticals IncEQUITIES(SNDX)20,0000-20,000$290.4K$0—-$290.4K
Vertex Pharmaceuticals IncEQUITIES(VRTX)13,7650-13,765$4.79M$0—-$4.79M
Voyager Therapeutics IncEQUITIES(VYGR)103,9660-103,966$805.7K$0—-$805.7K
Page 1 of 1
SILVERARC CAPITAL MANAGEMENT, LLC — 13F Holdings — Q4 2023 | TickerTrail